Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 01, 2018
Platelet BioGenesis has moved into brand new lab space in Cambridge, MA.
read more
Thursday, August 02, 2018
RegeneRx Biopharmaceuticals announced its licensee for RGN-137, GtreeBNT, has entered into a joint venture with YuYang DNU to develop RGN-137 on a global basis for the orphan indication, epidermolysis bullosa.
read more
Thursday, August 02, 2018
LifeSciences and Particle Sciences have received a Notice of Allowance on a device for the delivery of medication to the ear-drum.
read more
Thursday, August 02, 2018
MilliporeSigma and InnoCore Pharmaceuticals have entered into a global cooperation agreement to provide InnoCore’s proprietary SynBiosys biodegradable polymer platform.
read more
Thursday, August 02, 2018
LSPediA announced a new business relationship with MAGNA Pharmaceuticals.
read more
Marken has announced the opening of a new branch located in Melbourne.
read more
The FDA has awarded a $2 million grant to the Rutgers University Center for Structured Organic Particulate Systems for Continuous Pharmaceutical Manufacturing.
read more
Abzena has entered into a master service agreement with NYU Langone Health.
read more
Lannett has entered into an exclusive perpetual licensing agreement with Andor for Methylphenidate Hydrochloride ER tablets USP (CII) in 18 mg, 27 mg, 36 mg and 54 mg strengths.
read more
bluebird bio and Regeneron announced a collaboration to apply their respective technology platforms to the discovery, development and commercialization of novel immune cell therapies for cancer.
read more
Abdi Ibrahim has selected rfxcel to implement and support new compliance management and serialization processing software.
read more
OncoSec has entered into a research collaboration agreement with the University of California, Los Angeles on behalf of Roger S. Lo, M.D., Ph.D. and his research team
read more
Can-Fite BioPharma has signed a License, Collaboration and Distribution Agreement with CMS Medical for Piclidenoson for rheumatoid arthritis and psoriasis and Namodenoson for advanced liver cancer.
read more
Glenmark Pharmaceuticals and Harbour BioMed have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 1302.
read more
Immune Biosolutions announced a research collaboration and license agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
read more